Literature DB >> 6263986

Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures.

Y Asano, K Shiraki, M Takahashi, H Nagai, T Ozaki, T Yazaki.   

Abstract

A soluble varicella virus antigen for skin testing was developed using culture fluid from varicella-zoster virus-infected human diploid cells. The culture fluid was centrifuged at a high speed (100,000 g for 2 hr) to remove viral particles, and the supernatant, after heating at 56 C for 30 min, was used as the soluble skin test antigen. No virion or nucleocapsid was found by electron microscopy, and very little 3 H-labeled DNA in the soluble antigen hybridized with viral DNA. By immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and fluorography, several viral glycoprotein bands were detected in the soluble antigen. In a comparative skin test on 10 medical students and 10 children using soluble and crude antigens prepared from culture fluid or infected cells, the skin reaction to the soluble antigen tended to be less than that to the crude antigens, but the former reaction correlated well with a history of varicella and the presence or absence of virus-neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263986     DOI: 10.1093/infdis/143.5.684

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

3.  Experimental infection and immune response of guinea pigs with varicella-zoster virus.

Authors:  Y Matsunaga; K Yamanishi; M Takahashi
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Human natural killer cells mediate adaptive immunity to viral antigens.

Authors:  Rana Nikzad; Laura S Angelo; Kevin Aviles-Padilla; Duy T Le; Vipul K Singh; Lynn Bimler; Milica Vukmanovic-Stejic; Elena Vendrame; Thanmayi Ranganath; Laura Simpson; Nancy L Haigwood; Catherine A Blish; Arne N Akbar; Silke Paust
Journal:  Sci Immunol       Date:  2019-05-10

5.  Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans.

Authors:  Milica Vukmanovic-Stejic; Daisy Sandhu; Toni O Sobande; Elaine Agius; Katie E Lacy; Natalie Riddell; Sandra Montez; One B Dintwe; Thomas J Scriba; Judith Breuer; Janko Nikolich-Zugich; Graham Ogg; Malcolm H A Rustin; Arne N Akbar
Journal:  J Immunol       Date:  2013-01-02       Impact factor: 5.422

6.  Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

Authors:  Y Okuno; Y Takao; Y Miyazaki; F Ohnishi; M Okeda; S Yano; H Kumihashi; Y Gomi; K Maeda; T Ishikawa; Y Mori; H Asada; H Iso; K Yamanishi
Journal:  Epidemiol Infect       Date:  2012-12-10       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.